Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KLEEBERG U")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 40

  • Page / 2

Export

Selection :

  • and

DIE PHOSPHOGLUKOSE-ISOMERASE-EIN DIAGNOSTISCHES KRITERIUM DER PSORIASIS VULGARIS. = LA PHOSPHOGLUCO-ISOMERASE, UN CRITERE DIAGNOSTIQUE DU PSORIASIS.MEYER J; KLEEBERG U.1972; DERMATOL. MONATSSCHR.; DTSCH.; DA. 1972; VOL. 158; NO 9; PP. 620-625; BIBL. 16 REF.Serial Issue

Indikationen, Wirkung, Nutzen und Sinn einer palliativen Behandlung tumorkranker Menschen = Indications of palliative care in malignant tumorsKLEEBERG, U. R.Geburtshilfe und Frauenheilkunde. 1999, Vol 59, Num 5, pp M57-M60, issn 0016-5751Article

Die Rolle des Onkologen bei der psychologischen Betreuung seiner Patienten = Le rôle de l'oncologue dans les soins psychologiques accordés à ses patients = The role of the oncologist in the psychological care for his patientsKLEEBERG, U. R.Psychotherapie, Psychosomatik, medizinische Psychologie. 1986, Vol 36, Num 3-4, pp 130-135, issn 0173-7937Article

EFFECT OF 3-METHYLCHOLANTHRENE ON RNA POLYMERASE AND PROTEIN KINASE ACTIVITIES OF TRANSCRIPTIONALLY ACTIVE CHROMATIN SUBFRACTION IN RAT LIVERSZEBERENYI J; KLEEBERG U; TIGYI A et al.1982; EXPERIENTIA; ISSN 0014-4754; CHE; DA. 1982; VOL. 38; NO 6; PP. 687-689; BIBL. 18 REF.Article

PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma: a pilot study = Polychimiothérapie par PALA, vindésine et cisplatine dans les mélanones malins avancés. Une étude piloteVOIGT, H; KLEEBERG, U. R.Cancer. 1984, Vol 53, Num 10, pp 2058-2062, issn 0008-543XArticle

INFLUENCE OF 3-METHYLCHOLANLANTHRENE ON LIVER NUCLEOLAR AND NUCLEOPLASMIC ACTIVITIES OF PROTEIN KINASES AND RNA POLYMERASESKLEEBERG U; SZEBERENYI J; JUHASZ P et al.1982; BIOCHEM. PHARMACOL.; ISSN 0006-2952; USA; DA. 1982; VOL. 31; NO 6; PP. 1063-1067; BIBL. 47 REF.Article

EFFECT OF 3-METHYLCHOLANTHRENE ON THE BILIARY EXCRETION OF BROMSULPHALEIN AND EOSINE IN NEWBORN RATSKLEEBERG U; FISCHER E; GREGUS Z et al.1979; ACTA PHYSIOL. ACAD. SCI. HUNGAR.; HUN; DA. 1979; VOL. 53; NO 3; PP. 363-367; ABS. RUS; BIBL. 17 REF.Article

Extrapolation vom Tierversuch auf Reaktionen beim Menschen = L'extrapolation de l'essai sur l'animal aux réactions chez l'homme = Extrapolation from animal experiments to reactions in manKLINGER, W; MÜLLER, D; KLEEBERG, U et al.Pharmazie. 1983, Vol 38, Num 9, pp 621-623, issn 0031-7144Article

N,N-DIETHYL-4-AMINOAZOBENZENE (DEAB): ACUTE ACTIONS WITH RESPECT TO POSSIBLE CARCINOGENICITY AS WELL AS THE ROLE OF SOLVENTS. MORPHOLOGICAL AND PHARMACOLOGICAL INVESTIGATIONSDANZ M; MULLER D; KLEEBERG U et al.1978; EXPER. PATHOL.; DDR; DA. 1978; VOL. 16; NO 1-6; PP. 245-253; BIBL. 1 P.Article

CONGENITAL STOMATOCYTOSIS AND CHRONIC HAEMOLYTIC ANAEMIA = STOMATOCYTOSE CONGENITALE ET ANEMIE HEMOLYTIQUE CHRONIQUEBIENZLE U; NIETHAMMER D; KLEEBERG U et al.1975; SCAND. J. HAEMATOL.; DENM.; DA. 1975; VOL. 15; NO 5; PP. 339-346; BIBL. 1 P. 1/2Article

Low-dose cytarabine: chromosomal findings suggesting its cytostatic as well as differentiating effectHOSSFELD, D. K; WEH, H.-J; KLEEBERG, U. R et al.Leukemia research. 1985, Vol 9, Num 2, pp 329-330, issn 0145-2126Article

Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H+/K+-ATPase inhibitors and other xenobioticsKRUSEKOPF, S; ROOTS, I; HILDEBRANDT, A. G et al.Xenobiotica (London. Print). 2003, Vol 33, Num 2, pp 107-118, issn 0049-8254, 12 p.Article

Effects of benzimidazole derivatives on cytochrome p450 1A1 expression in a human hepatoma cell lineKRUSEKOPF, S; KLEEBERG, U; HILDEBRANDT, A. G et al.Xenobiotica (London. Print). 1997, Vol 27, Num 1, pp 1-9, issn 0049-8254Article

Phase I study of pirarubicinMILLER, A. A; SCHEULEN, M. E; KLEEBERG, U. R et al.Journal of cancer research and clinical oncology. 1988, Vol 114, Num 1, pp 91-94, issn 0171-5216Article

Chlorinated drinking water is mutagenic and causes 3-methylcholanthrene type induction of hepatic monooxygenaseLIIMATAINEN, A; MÜLLER, D; VARTIAINEN, T et al.Toxicology (Amsterdam). 1988, Vol 51, Num 2-3, pp 281-289, issn 0300-483XArticle

The influence of essential phospholipids (EPL) on phase-I- and phase-II-reactions and on the glutathione status in the liver of aging ratsKLINGER, W; MÜLLER, D; KLEEBERG, U et al.Experimental pathology (1981). 1991, Vol 41, Num 3, pp 151-156, issn 0232-1513Article

Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer: a phase II study of the association of medical oncology of the German cancer society (AIO)WANDER, H.-E; NAGEL, G. A; BLOSSEY, H.-C et al.Cancer. 1986, Vol 58, Num 9, pp 1985-1989, issn 0008-543XArticle

Sequential methotrexate and 5-fluorouracil (FU) vs. FU alone in metastatic colorectal cancer: results of a randomized multicenter trialHERRMANN, R; KNUTH, A; KLEEBERG, U et al.Annals of oncology. 1992, Vol 3, Num 7, pp 539-543, issn 0923-7534Article

Current guidelines for the preclinical safety assessment of therapeutic proteinsBASS, R; KLEEBERG, U; SCHRÖDER, H et al.Toxicology letters. 1992, Vol 64-65, pp 339-347, issn 0378-4274Conference Paper

Sensitivity, selectivity and specificity of monoclonal antibodies directed at tumor-associated antigens from metastatic melanomaKLEEBERG, U. R; LOYCKE, A; MEIER, T et al.European journal of cancer & clinical oncology. 1988, Vol 24, pp 47-50, issn 0277-5379, suppl. 2Article

Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma: a phase study of the EORTC malignant melanoma cooperative groupVERSCHAEGREN, C. F; KLEEBERG, U. R; MULDER, J et al.Cancer. 1988, Vol 62, Num 6, pp 1061-1065, issn 0008-543XArticle

An assessment of DTIC versus levamisole or placebo in the treatment of high risk stage I patients after surgical removal of a primary melanoma of the skin. A phase III adjuvant study. EORTC protocol 18761LEJEUNE, F. J; MACHER, E; KLEEBERG, U et al.European journal of cancer & clinical oncology. 1988, Vol 24, pp 81-90, issn 0277-5379, suppl. 2Article

Postmenopausal women who progress on fulvestrant ('Faslodex') remain sensitive to further endocrine therapyVERGOTE, I; ROBERTSON, J. F. R; KLEEBERG, U et al.Breast cancer research and treatment. 2003, Vol 79, Num 2, pp 207-211, issn 0167-6806, 5 p.Article

Melanoma and use of sunscreens : and EORTC case-control study in Germany, Belgium and FranceAUTIER, P; DORE, J.-F; JOARLETTE, M et al.International journal of cancer. 1995, Vol 61, Num 6, pp 749-755, issn 0020-7136Article

Melanoma risk and residence in sunny areasAUTIER, P; DORE, J. F; GEFELLER, O et al.British journal of cancer. 1997, Vol 76, Num 11, pp 1521-1524, issn 0007-0920Article

  • Page / 2